CryoLife (NYSE: CRY) reported Q2 EPS of $0.07, versus ($0.02) reported last year. Revenue for the quarter came in at $47.1 million, versus $35.5 million reported last year.

GUIDANCE:

CryoLife sees Q3 2016 EPS of $0.32-$0.32, versus prior guidance of $0.29-$0.32. CryoLife sees Q3 2016 revenue of $180-182 million, versus prior guidance of $178-180 million.

For earnings history and earnings-related data on CryoLife (CRY) click here.